GASTRIC ADENOCARCINOMA: PART II
by Neil P. Phelan, John M. Levey and JeanMarie Houghton
Because screening programs for patients with gastric adenocarcinoma are not used in the United States, patients are usually diagnosed when symptoms occur. Symptoms do not occur until the cancer has metastasized to distant organs. This paper covers the clinical manifestations, through diagnosis/diagnostic testing, and therapy.
The Hitchhiker’s Guide to Parenteral Nutrition Management for Adult Patients
by Howard Madsen and Eric H. Frankel
This article will aid the clinician in the safe provision of parenteral nutrition support, including development of prescription, appropriate monitoring and awareness of the issues involved in the preparation and stability of commonly used additives. Frequently asked questions regarding parenteral nutrition are also addressed.
Localized Gastric Amyloidosis
by Ashutosh Niraj, Nolan E. Perez, Nabiha Sakr-Khoury,
Volkan Adsay, Olca Basturk, Martin Tobi and Nadeem Ullah Stomach and gastrointestinal tract involvement is a common feature of systemic amyloidosis—localized gastric involvement is very rare. This is one of those rare cases, localized amyloidosis which was found at endoscopy and confirmed by biopsy.
by Raymond B. Bedgood and Ayaz Chaudhary and assisted by Kavita Kongara and Douglas Katz
A case for you to solve.
Safe and Effective Use of Immunomodulators for Inflammatory Bowel Disease
by Corey A. Siegel
This article gives a practical approach for the use of 6-mercaptopurine, azathioprine and methotrexate—the most commonly used immunomodulators for inflammatory bowel disease. Also, overed here is dosing and monitoring recommendations, genetic testing, and long-term risks and benefits.